UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

---

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):

 

January 24, 2011 (January 24, 2011)

 

---

 

HARRIS & HARRIS GROUP, INC. 

---

(Exact name of registrant as specified in its charter)

 

New York (State or other jurisdiction of incorporation)

0-11576 (Commission File Number)

13-3119827 (IRS Employer Identification No.)

 

---

 

1450 Broadway

New York, New York 10018

---

(Address of principal executive offices and zip code)

 

(212) 582-0900

---

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

---

 

Item 7.01.     Regulation FD Disclosure.

On January 24, 2011, Harris & Harris Group, Inc. (the “Company”) issued a press release disclosing that Amgen (NASDAQ: AMGN) and BioVex Group, Inc., had announced that the companies have entered into a definitive acquisition agreement under which Amgen has agreed to acquire BioVex Group.  The Company is an investor in privately held BioVex Group.  The transaction is subject to customary closing conditions, including regulatory approvals, and is expected to close in the first quarter of 2011. A copy of the Company's press release issued January 24, 2011, is attached as Exhibit 99.1.

 

Item 9.01.     Financial Statements and Exhibits.

 

(a)

Not applicable.

(b)

Not applicable.

(c)

Not applicable.

(d)

Exhibits.

Exhibit No.	Description
99.1	Press Release, dated January 24, 2011

 

---

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: January 24, 2011	HARRIS & HARRIS GROUP, INC.
	By:	/s/ Douglas W. Jamison
		Douglas W. Jamison
		Chief Executive Officer

 

---

 

EXHIBIT INDEX

Exhibit No.	Description
99.1	Press Release, dated January 24, 2011

---